Concluding Remarks for Special Issue HTLV-HIV Co-Infections
Viruses · 2023
DOI: 10.3390/v15040963 ↗Kurz gefasst
Editorial in der Zeitschrift Viruses, 2023. Verfasst von Alejandro Vallejo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunovirology, Infectious Diseases Department, Health Research Institute Ramon y Cajal (IRyCIS), Ramon y Cajal University Hospital, 28…. Hauptthemen laut MEDLINE: Human T-lymphotropic virus 1, HTLV-I Infections, Coinfection, HIV Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
During the early 1980s, the first 3 human retroviruses were identified: human T-lymphotropic virus 1 and 2 (HTLV-1 and HTLV-2) and human immunodeficiency virus (HIV) [...]
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Laboratory of Immunovirology, Infectious Diseases Department, Health Research Institute Ramon y Cajal (IRyCIS), Ramon y Cajal University Hospital, 28034 Madrid, Spain.
- UNC HIV Cure Center, University of North Carolina, Chapel Hill, NC 27599, USA.
ORCID-Profile: Alejandro Vallejo
Zitieren
APA
Vallejo, A., & Abad-Fernández, M. (2023). Concluding Remarks for Special Issue HTLV-HIV Co-Infections. Viruses. https://doi.org/10.3390/v15040963
Vancouver
Vallejo A, Abad-Fernández M. Concluding Remarks for Special Issue HTLV-HIV Co-Infections. Viruses. 2023. doi:10.3390/v15040963
BibTeX
@article{Vallejo2023,
author = {Vallejo, Alejandro and Abad-Fernández, María},
title = {Concluding Remarks for Special Issue HTLV-HIV Co-Infections},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15040963}
}
EUVIMED